Modulation of Vaccine-Induced HIV-1-Specific Immune Responses by Co-Electroporation of PD-L1 Encoding DNA.

HIV-1 checkpoint blockade checkpoint inhibitors immunomodulation intramuscular electroporation soluble immune checkpoints

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
14 Jan 2020
Historique:
received: 17 12 2019
revised: 09 01 2020
accepted: 10 01 2020
entrez: 18 1 2020
pubmed: 18 1 2020
medline: 18 1 2020
Statut: epublish

Résumé

The importance of a balanced T

Identifiants

pubmed: 31947643
pii: vaccines8010027
doi: 10.3390/vaccines8010027
pmc: PMC7157229
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : The European Union's Horizon 2020 research and innovation programme
ID : Grant agreement No. 681137
Organisme : The Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg
ID : Project A73

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Curr Opin Immunol. 2011 Jun;23(3):421-9
pubmed: 21530212
Retrovirology. 2013 Oct 24;10:117
pubmed: 24156704
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12293-7
pubmed: 12218188
PLoS One. 2012;7(6):e39038
pubmed: 22720025
J Exp Med. 2006 Oct 2;203(10):2223-7
pubmed: 17000870
Virology. 2009 Jun 20;389(1-2):108-21
pubmed: 19410272
N Engl J Med. 2009 Dec 3;361(23):2209-20
pubmed: 19843557
Nat Immunol. 2010 Jun;11(6):535-42
pubmed: 20453843
Sci Transl Med. 2014 Mar 19;6(228):228ra38
pubmed: 24648341
J Virol. 2008 Dec;82(23):11651-68
pubmed: 18815292
Viruses. 2019 Feb 13;11(2):
pubmed: 30781796
N Engl J Med. 2010 Aug 19;363(8):711-23
pubmed: 20525992
Immunology. 2016 Nov;149(3):320-328
pubmed: 27421990
Science. 2019 May 10;364(6440):558-566
pubmed: 31000591
Annu Rev Med. 2015;66:423-37
pubmed: 25341006
Clin Cancer Res. 2016 Jun 15;22(12):2969-80
pubmed: 26755531
N Engl J Med. 2012 Jun 28;366(26):2443-54
pubmed: 22658127
AIDS Res Hum Retroviruses. 1988 Feb;4(1):3-9
pubmed: 3163253
J Immunol. 2015 Nov 15;195(10):4861-72
pubmed: 26466954
Immunity. 1999 Aug;11(2):141-51
pubmed: 10485649
Sci Rep. 2017 Oct 25;7(1):14049
pubmed: 29070883
Clin Vaccine Immunol. 2014 Aug;21(8):1023-36
pubmed: 24920599
N Engl J Med. 2012 Apr 5;366(14):1275-86
pubmed: 22475592
J Virol. 2018 Jun 29;92(14):
pubmed: 29743369
Sci Transl Med. 2014 Mar 19;6(228):228ra39
pubmed: 24648342
Immunity. 2009 May;30(5):731-43
pubmed: 19427241
Nature. 2006 Sep 21;443(7109):350-4
pubmed: 16921384
Nat Med. 2006 Oct;12(10):1198-202
pubmed: 16917489
Nature. 2009 Mar 12;458(7235):206-10
pubmed: 19078956
Curr Opin HIV AIDS. 2009 Sep;4(5):373-9
pubmed: 20048700
J Immunol. 2001 Feb 1;166(3):2133-40
pubmed: 11160265
Immunity. 2018 Aug 21;49(2):264-274.e4
pubmed: 30076099
Elife. 2019 Nov 15;8:
pubmed: 31729316
Asian Pac J Cancer Prev. 2012;13(8):4031-6
pubmed: 23098512
Clin Exp Immunol. 1989 May;76(2):216-21
pubmed: 2503275
J Virol. 2014 Apr;88(8):3997-4007
pubmed: 24453366
N Engl J Med. 2018 Jan 11;378(2):158-168
pubmed: 29320654
J Immunol. 2009 May 15;182(10):5891-7
pubmed: 19414738
Nat Rev Immunol. 2018 Feb;18(2):91-104
pubmed: 28990586
Am J Kidney Dis. 2004 Jul;44(1):42-9
pubmed: 15211436
PLoS Pathog. 2016 Jan 08;12(1):e1005315
pubmed: 26745376
Front Immunol. 2018 Oct 17;9:2374
pubmed: 30386337
J Immunother. 2011 Apr;34(3):297-306
pubmed: 21389868
Immunity. 2010 Oct 29;33(4):492-503
pubmed: 21029960
Eur J Cancer. 2017 Aug;81:135-137
pubmed: 28624693
PLoS Pathog. 2016 Jan 07;12(1):e1005349
pubmed: 26741490
PLoS Pathog. 2016 Aug 31;12(8):e1005817
pubmed: 27579713
Nat Immunol. 2007 Mar;8(3):239-45
pubmed: 17304234
J Immunol. 2018 Aug 1;201(3):971-981
pubmed: 29934472
Hum Gene Ther. 2000 Nov 20;11(17):2403-13
pubmed: 11096444

Auteurs

Pierre Tannig (P)

Institute of Clinical and Molecular Virology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen 91054, Germany.

Antonia Sophia Peter (AS)

Institute of Clinical and Molecular Virology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen 91054, Germany.

Dennis Lapuente (D)

Institute of Clinical and Molecular Virology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen 91054, Germany.

Stephan Klessing (S)

Institute of Clinical and Molecular Virology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen 91054, Germany.

Dominik Damm (D)

Institute of Clinical and Molecular Virology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen 91054, Germany.

Matthias Tenbusch (M)

Institute of Clinical and Molecular Virology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen 91054, Germany.

Klaus Überla (K)

Institute of Clinical and Molecular Virology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen 91054, Germany.

Vladimir Temchura (V)

Institute of Clinical and Molecular Virology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen 91054, Germany.

Classifications MeSH